Carboxamide Derivatives Multi-Target Anti-Inflammatory Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for inflammatory conditions, such as rheumatoid arthritis, are limited by lack of efficacy, development of resistance, unacceptable side effects, and high expense.
Innovation Solution
Development of compounds with a broad anti-inflammatory spectrum that exert a multi-target action, significantly affecting cytokines and chemokines involved in the inflammation process, thereby reducing the production of pro-inflammatory chemokines and cytokines.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If corticosteroids are used to treat inflammation, then anti-inflammatory effect is improved, but severe side effects occur including elevation of blood pressure, salt and water retention, kidney damage, and increased potassium and calcium excretion
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of anti-inflammatory compounds through specific substitutions at defined positions in the molecular framework. This structural parameter modification aims to achieve reduced side effects while maintaining therapeutic efficacy, directly addressing the contradiction between effectiveness and safety of corticosteroid treatment
Solution Approach 2:
The patent employs composite material principles by creating hybrid molecular structures that combine different functional groups and structural elements. These composite chemical structures are designed to provide multi-target anti-inflammatory activity while reducing the harmful side effects associated with conventional corticosteroids
2Reliability
If methotrexate is used to treat rheumatoid arthritis, then disease modification is improved, but substantial side effects occur such as severe skin reactions, infections, liver damage, kidney damage, lung damage, and gastrointestinal tract damage
Solution Approach 1:
The patent applies parameter changes by systematically varying chemical parameters such as substituent groups, molecular weight, and structural configuration to develop compounds with improved safety profiles. This approach seeks to maintain disease-modifying efficacy while reducing the severe multi-organ side effects of methotrexate
Solution Approach 2:
The patent introduces intermediary compounds that act as mediators between the patient's immune system and the disease process. These intermediate molecular structures provide alternative pathways for immune modulation that avoid the direct toxic effects on liver, kidneys, lungs, and gastrointestinal tract associated with methotrexate
3Reliability
If gold agents are used to treat inflammatory conditions, then anti-inflammatory effect is improved, but side effects occur including oral ulcers, altered taste, serious skin rashes, renal problems, enterocolitis, liver injury, and lung disease
Solution Approach 1:
The patent applies parameter changes by modifying chemical parameters including molecular size, charge distribution, and functional group composition to create gold-free compounds. These parameter modifications aim to replicate the anti-inflammatory benefits of gold agents while eliminating their characteristic side effects such as oral ulcers, skin rashes, and organ damage
4Reliability
If non-steroidal anti-inflammatory drugs are used to treat inflammation, then anti-inflammatory effect is improved, but they cause gastrointestinal side effects and may not be effective for all inflammatory conditions
Solution Approach 1:
The patent applies universality by designing compounds with multi-functional capabilities that can address various types of inflammation through multiple mechanisms of action. This multi-functionality allows the compounds to be effective across different inflammatory conditions while reducing reliance on any single mechanism that might cause gastrointestinal side effects
Solution Approach 2:
The patent applies parameter changes by modifying chemical structure parameters to reduce gastrointestinal irritation while maintaining anti-inflammatory efficacy. This includes adjusting molecular properties such as solubility, stability, and interaction with gastrointestinal tissues to minimize local side effects
Data Source
AI summary
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt, hydrate, or isomer thereof. The invention also provides pharmaceutical compositions comprising the compounds of formula (I) as well as their use in therapy, particularly in the treatment of inflammatory conditions. Advantageously, the compounds of the invention show a broad and robust anti-inflammatory effect, and are therapeutically safe.